トップページ ＞Mitsubishi Tanabe Pharma Sustainability Report 2025
田辺三菱製薬 ｻｽﾃﾅﾋﾞﾘﾃｨ報告2025※2025年12月1日より､田辺三菱製薬は田辺ﾌｧｰﾏに社名変更しました｡
Mitsubishi Tanabe Pharma Sustainability Report 2024
田辺三菱製薬 ｻｽﾃﾅﾋﾞﾘﾃｨ報告2024
Mitsubishi Tanabe Pharma Sustainability Report 2023
田辺三菱製薬 ｻｽﾃﾅﾋﾞﾘﾃｨ報告2023
Mitsubishi Tanabe Pharma Sustainability Report 2022
田辺三菱製薬 ｻｽﾃﾅﾋﾞﾘﾃｨ報告2022
田辺三菱製薬 ｻｽﾃﾅﾋﾞﾘﾃｨ報告2021
田辺三菱製薬 ｻｽﾃﾅﾋﾞﾘﾃｨ報告2020
Mitsubishi Tanabe Pharma Sustainability Report 2020
田辺三菱製薬 CSR活動報告2019
田辺三菱製薬 CSR活動報告2018
田辺三菱製薬 ｺｰﾎﾟﾚｰﾄﾚﾎﾟｰﾄ2017
田辺三菱製薬 ｺｰﾎﾟﾚｰﾄﾚﾎﾟｰﾄ2016
Mitsubishi Tanabe Pharma Sustainability Report 2025
■発行月 / 2025年12月 ■総ページ数 / 213P
■業種 / 医薬品
■従業員数 / 3001人～5000人
■売上高 / 3001億～5000億 ■本社所在地 / 大阪府
■言語 / 英語(Engl.) ■登録日 / 2026/01/05
報告書概要
Based on a history spanning more than 300 years, and our frontier spirit, the Tanabe Pharma Group’s MISSION “Creating hope for all facing illness.” reflects universal values, and the realization of that philosophy is our social mission.
This Report is intended to provide the Group's stakeholders, including patients, healthcare professionals, local communities, and employees, with information about major sustainability initiatives implemented by the Group in the previous fiscal year. Specific initiatives implemented in accordance with the Company's philosophy are presented in line with management, the environment, and society.
※Mitsubishi Tanabe Pharma to rebrand as “Tanabe Pharma” on December 1, 2025.
The content of this PDF was edited based on the Japanese version of our Sustainability website as of September 25, 2025, and was published on December 1, 2025, at the time of the company name change.
この報告書発行企業の外部リンク
ONO PHARMACEUTICAL CO., LTD.
ONO PHARMACEUTICAL Corporate Report 2015
｜
